Literature DB >> 16061432

Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.

G Remaud1, M Boisdron-Celle, A Morel, A Gamelin.   

Abstract

Ftorafur (FT), an oral prodrug of 5-FU, is part of UFT and S1, two oral prodrugs widely used in digestive tract cancer. We set up a liquid chromatography tandem mass spectrometry (LC/MS-MS) method, chosen for its specificity of detection, for simultaneously measuring in human plasma FT, 5-FU and 5-FUH2. Separation was performed on a Hypercarb column. Linearity, precision and accuracy were validated in the concentration range studied for each compound. This simple and reliable LC/MS-MS method allows specific, sensitive and reproducible quantification of FT, 5-FU and FUH2 in human plasma and can be applied to further pharmacokinetic studies in patients treated with FT-based prodrugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061432     DOI: 10.1016/j.jchromb.2005.07.023

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells.

Authors:  Debanjan Chakroborty; Chandrani Sarkar; Hongmei Yu; Jiang Wang; Zhongfa Liu; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  The achievement of mass balance by simultaneous quantification of floxuridine prodrug, floxuridine, 5-fluorouracil, 5-dihydrouracil, α-fluoro-β-ureidopropionate, α-fluoro-β-alanine using LC-MS.

Authors:  Yasuhiro Tsume; Chester J Provoda; Gordon L Amidon
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-05       Impact factor: 3.205

3.  Pharmacokinetic application of a bio-analytical LC-MS method developed for 5-fluorouracil and methotrexate in mouse plasma, brain and urine.

Authors:  Vaishnavi Ganti; Ellen A Walker; Swati Nagar
Journal:  Biomed Chromatogr       Date:  2013-03-12       Impact factor: 1.902

4.  In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice.

Authors:  Na Zheng; Mingyao Zhou; Wen Lu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-11-22       Impact factor: 2.441

Review 5.  A Critical Review on Clinical Application of Separation Techniques for Selective Recognition of Uracil and 5-Fluorouracil.

Authors:  Khushaboo Pandey; Rama Shankar Dubey; Bhim Bali Prasad
Journal:  Indian J Clin Biochem       Date:  2015-02-15

6.  Tegafur and 5-fluorouracil levels in tears and changes in tear volume in long-term users of the oral anticancer drug S-1.

Authors:  Reiko Kuriki; Tsuyoshi Hata; Kinuyo Nakayama; Yuichi Ito; Kazunari Misawa; Seiji Ito; Michiko Tatematsu; Norio Kaneda
Journal:  Nagoya J Med Sci       Date:  2019-08       Impact factor: 1.131

Review 7.  Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy.

Authors:  Robert B Diasio; Steven M Offer
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

8.  A novel 5-Fluorocuracil multiple-nanoemulsion used for the enhancement of oral bioavailability in the treatment of colorectal cancer.

Authors:  Niyaz Ahmad; Ahmed A Albassam; Mohd Faiyaz Khan; Zabih Ullah; Taysser Mohammed Buheazah; Hussain Salman AlHomoud; Hassan Ali Al-Nasif
Journal:  Saudi J Biol Sci       Date:  2022-03-14       Impact factor: 4.052

9.  Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.

Authors:  Jian Gao; Rui Zhen; Hai Liao; Wenquan Zhuang; Wenbo Guo
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.